Editor

FRANCISCO  M GONZALEZ OTERO
fco_gonzalez
[+info]

Directorio Médico

address_bookVisite nuestro Directorio Médico, la más completa base de datos de especialistas iberoamericanos en Dermatología Pediátrica
ir al Directorio Médico

Escríbanos

mailComunicarse con nosotros, le responderemos tan pronto sea posible, leemos todos los correos recibidos. Haga clic aquí para ir a nuestro formulario de contacto
Página de Inicio arrow Artículos Científicos arrow Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis Imprimir E-Mail
1, Pediatric Drugs:
1 December 2009 - Volume 11 - Issue 6 - pp 407-426

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Yang, Lily P.H.; Curran, Monique P.
Abstract
Abstract: Topical pimecrolimus 1% cream (Elidel®) [hereafter referred to as topical pimecrolimus] is a nonsteroidal alternative in the treatment of pediatric atopic dermatitis. In vehicle-controlled, short-term, continuous-use trials in pediatric patients with mild to moderate atopic dermatitis, topical pimecrolimus was effective in treating disease symptoms. Topical pimecrolimus was effective in preventing disease flares and reducing the need for topical corticosteroids in longer term, intermittent-use trials. In addition, topical pimecrolimus was associated with improvements in the health-related quality of life (HR-QOL) of pediatric patients with atopic dermatitis and their parents. In vehicle-controlled trials, topical pimecrolimus was generally as well tolerated as vehicle. Topical pimecrolimus showed similar efficacy to topical tacrolimus 0.03% ointment (hereafter topical tacrolimus) in a short-term, continuous-use trial and the two agents had a generally similar tolerability profile. Although comparative data between topical pimecrolimus and topical corticosteroids are lacking in pediatric patients, and the long-term tolerability (beyond 1-2 years) of topical pimecrolimus is yet to be established, topical pimecrolimus is a useful agent in the management of pediatric patients with mild to moderate atopic dermatitis who do not achieve satisfactory treatment with other topical pharmacologic treatments, including topical corticosteroids.
 
< Anterior   Siguiente >
[Volver]

Conferencias Científicas

Traemos a todos los especialistas, un repositorio de conferencias y charlas sobre temas de interés médico y formación de nuevas generaciones especialistas. Invitamos a visitar nuestra galería de Conferencias .